Correlation Between Defence Therapeutics and Institute

Can any of the company-specific risk be diversified away by investing in both Defence Therapeutics and Institute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Defence Therapeutics and Institute into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Defence Therapeutics and Institute of Biomedical, you can compare the effects of market volatilities on Defence Therapeutics and Institute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Defence Therapeutics with a short position of Institute. Check out your portfolio center. Please also check ongoing floating volatility patterns of Defence Therapeutics and Institute.

Diversification Opportunities for Defence Therapeutics and Institute

-0.03

Correlation Coefficient

Defence Therapeutics  Institute

Good diversification

The 3 months correlation between Defence and Institute is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Defence Therapeutics and Institute of Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Institute of Biomedical and Defence Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Defence Therapeutics are associated (or correlated) with Institute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Institute of Biomedical has no effect on the direction of Defence Therapeutics i.e., Defence Therapeutics and Institute go up and down completely randomly.

Pair Corralation between Defence Therapeutics and Institute

Assuming the 90 days horizon Defence Therapeutics is expected to generate 41.03 times less return on investment than Institute. But when comparing it to its historical volatility, Defence Therapeutics is 38.49 times less risky than Institute. It trades about 0.21 of its potential returns per unit of risk. Institute of Biomedical is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  0.37  in Institute of Biomedical on September 12, 2024 and sell it today you would earn a total of  0.37  from holding Institute of Biomedical or generate 100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Defence Therapeutics  vs.  Institute of Biomedical

Defence Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Defence Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical and fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Institute of Biomedical

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Institute of Biomedical are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak technical and fundamental indicators, Institute unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Defence Therapeutics and Institute

The main advantage of trading using opposite Defence Therapeutics and Institute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Defence Therapeutics position performs unexpectedly, Institute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Institute will offset losses from the drop in Institute's long position.

The idea behind Defence Therapeutics and Institute of Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.